Substantially Improving the cure rate of high-risk BRCA1-like breast cancer patients with personalized therapy (SUBITO). An international randomized phase III trial

Details

Database :

OpenAIRE

Accession number :

edsair.doi...........3389d18e6873ca9ee30fb022f95fc593

Full Text :

https://doi.org/10.13140/rg.2.2.28059.77602